Physician profile
Patrick T Tran
NPI 1104384791
$4,232.83
in general payments reported to CMS, 2019-2025
12 companies · $3,855 in 2025
The $3,855 reported for 2025 was more than what 83% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $162 · 2024: $216 · 2025: $3,855.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,900 · Consulting Fee: $955.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,899.76 |
| Consulting Fee | $955.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,200.28 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Clottriever Bold Catheter |
| Ge Healthcare | $955.00 | 2025 | |
| Cook Medical LLC | $408.33 | 2025 | Zilver Vena, Gunther Tulip, Tornado |
| Boston Scientific Corporation | $357.95 | 2025 | General - Interventional Oncology, Embold Fibered, Obsidio |
| Siemens Medical Solutions USA, INC. | $245.52 | 2025 | |
| Penumbra, INC. | $245.17 | 2025 | Indigo System |
| Balt USA, LLC | $207.86 | 2025 | Prestige Coil System |
| Lilly USA, LLC | $96.02 | 2025 | Ebglyss |
| Okami Medical, INC. | $55.95 | 2025 | Lobo |
| Imperative Care, INC | $42.66 | 2025 | Zoom Rdl Radial Access System, 103cm |
| Bard Peripheral Vascular, INC. | $22.32 | 2025 | Venovo |
| Medtronic, INC. | $17.70 | 2025 | Osteocool Rf Ablation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.